SCHEMBL3268562

SCHEMBL3268562

COCCNc1cc(NCc2ccc(F)cc2OC)nc2ccc(Cl)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 3/20 0.41
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
GRK6 P43250 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4C Q9H3R0 1/20 0.40
NCF1 P14598 2/20 0.39
ALDH1A1 P00352 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
KDM4E B2RXH2 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
AURKA O14965 1/20 0.39
DAPK3 O43293 1/20 0.39
CHEK2 O96017 1/20 0.39
IGF1R P08069 1/20 0.39
GRK4 P32298 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3266976 0.87 NTRK1 (0.42) NTRK1HDAC3HDAC1HDAC2HDAC6
SCHEMBL3273799 0.84 KCNH2 (0.46) NTRK1MEN1KMT2ANCF1ALDH1A1
SCHEMBL3268434 0.84 NTRK1 (0.43) NTRK1HDAC3HDAC1HDAC2HDAC6
SCHEMBL3273200 0.80 ALDH1A1 (0.42) NTRK1MEN1KMT2AALDH1A1KDM4E
SCHEMBL3273719 0.80 NTRK1 (0.41) NTRK1GRK6MEN1KMT2AALDH1A1
SCHEMBL3267862 0.75 NPSR1 (0.48) GRK6KMT2AALDH1A1NPSR1KDM4E
SCHEMBL3268661 0.72 NPSR1 (0.54) ALDH1A1NPSR1KDM4ESMN1; SMN2RXFP1
SCHEMBL21796368 0.71 GRK6 (0.56) NTRK1GRK6MEN1KMT2AKDM4C
SCHEMBL3267078 0.71 ALDH1A1 (0.53) MEN1KMT2AALDH1A1NPSR1KDM4E
SCHEMBL3267029 0.69 DHFR (0.52) NTRK1MEN1KMT2AUSP2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399674-B2 Quinolines HOFFMAN-LA ROCHE INC. (US) 2013-03-19 US disclosed
US-20120136018-A1 QUINOLINES KOLCZEWSKI SABINE (DE) 2012-05-31 US disclosed
EP-2195296-A1 QUINOLINE DERIVATIVES AS 5HT5A RECEPTOR ANTAGONISTS F. Hoffmann-Roche AG (CH) 2010-06-16 EP disclosed
US-20090088451-A1 QUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2009-04-02 US disclosed
WO-2009040290-A1 QUINOLINE DERIVATIVES AS 5HT5A RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088451-A1 QUINOLINES HTR5A, HTR1A, HTR1E NTRK1 529/4885HDAC3 1814/4885HDAC1 2278/4885
US-20120136018-A1 QUINOLINES HTR5A, HTR1A, HTR1E NTRK1 529/4885HDAC3 1814/4885HDAC1 2278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.